Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A

被引:26
|
作者
Velazquez-Moctezuma, Rodrigo [1 ,2 ,3 ]
Law, Mansun [4 ]
Bukh, Jens [1 ,2 ,3 ]
Prentoe, Jannick [1 ,2 ,3 ]
机构
[1] Univ Copenhagen, Copenhagen Hepatitis C Program CO HEP, Dept Infect Dis, Copenhagen, Denmark
[2] Univ Copenhagen, Clin Res Ctr, Hvidovre Hosp, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark
[4] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
关键词
B TYPE-I; CELL-CULTURE SYSTEMS; E2; GLYCOPROTEIN; INFECTION; HCV; RECEPTOR; VACCINE; IDENTIFICATION; MUTATIONS; GENOTYPES;
D O I
10.1371/journal.ppat.1006214
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C virus (HCV) is a major cause of end-stage liver diseases. With 3-4 million new HCV infections yearly, a vaccine is urgently needed. A better understanding of virus escape from neutralizing antibodies and their corresponding epitopes are important for this effort. However, for viral isolates with high antibody resistance, or antibodies with moderate potency, it remains challenging to induce escape mutations in vitro. Here, as proof-of-concept, we used antibody-sensitive HVR1-deleted (.HVR1) viruses to generate escape mutants for a human monoclonal antibody, AR5A, targeting a rare cross-genotype conserved epitope. By analyzing the genotype 1a envelope proteins (E1/E2) of recovered CoreNS2 recombinant H77/JFH1(Delta HVR1) and performing reverse genetic studies we found that resistance to AR5A was caused by substitution L665W, also conferring resistance to the parental H77/JFH1. The mutation did not induce viral fitness loss, but abrogated AR5A binding to HCV particles and intracellular E1/E2 complexes. Culturing J6/JFH1(Delta HVR1) (genotype 2a), for which fitness was decreased by L665W, with AR5A generated AR5A-resistant viruses with the substitutions I345V, L665S, and S680T, which we introduced into J6/JFH1 and J6/JFH1(Delta HVR1). I345V increased fitness but had no effect on AR5A resistance. L665S impaired fitness and decreased AR5A sensitivity, while S680T combined with L665S compensated for fitness loss and decreased AR5A sensitivity even further. Interestingly, S680T alone had no fitness effect but sensitized the virus to AR5A. Of note, H77/JFH1(L665S) was non-viable. The resistance mutations did not affect cell-to-cell spread or E1/E2 interactions. Finally, introducing L665W, identified in genotype 1, into genotypes 2-6 parental and HVR1-deleted variants (not available for genotype 4a) we observed diverse effects on viral fitness and a universally pronounced reduction in AR5A sensitivity. Thus, we were able to take advantage of the neutralization-sensitive HVR1-deleted viruses to rapidly generate escape viruses aiding our understanding of the divergent escape pathways used by HCV to evade AR5A.
引用
收藏
页数:29
相关论文
共 50 条
  • [1] Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus
    Keck, Zhen-yong
    Girard-Blanc, Christine
    Wang, Wenyan
    Lau, Patrick
    Zuiani, Adam
    Rey, Felix A.
    Krey, Thomas
    Diamond, Michael S.
    Foung, Steven K. H.
    JOURNAL OF VIROLOGY, 2016, 90 (06) : 3112 - 3122
  • [2] Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry
    Prentoe, Jannick
    Bukh, Jens
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [3] A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
    Desombere, Isabelle
    Mesalam, Ahmed Atef
    Urbanowicz, Richard A.
    Van Houtte, Freya
    Verhoye, Lieven
    Keck, Zhen-Yong
    Farhoudi, Ali
    Vercauteren, Koen
    Weening, Karin E.
    Baumert, Thomas F.
    Patel, Arvind H.
    Foung, Steven K. H.
    Ball, Jonathan
    Leroux-Roels, Geert
    Meuleman, Philip
    ANTIVIRAL RESEARCH, 2017, 148 : 53 - 64
  • [4] Affinity Maturation of a Broadly Neutralizing Human Monoclonal Antibody That Prevents Acute Hepatitis C Virus Infection in Mice
    Keck, Zhen-Yong
    Wang, Yong
    Lau, Patrick
    Lund, Garry
    Rangarajan, Sneha
    Fauvelle, Catherine
    Liao, Grant C.
    Holtsberg, Frederick W.
    Warfield, Kelly L.
    Javad Aman, M.
    Pierce, Brian G.
    Fuerst, Thomas R.
    Bailey, Justin R.
    Baumert, Thomas F.
    Mariuzza, Roy A.
    Kneteman, Norman M.
    Foung, Steven K. H.
    HEPATOLOGY, 2016, 64 (06) : 1922 - 1933
  • [5] Recombinant antibody Fab against the hypervariable region 1 of hepatitis C virus blocks the virus adsorption to susceptible cells in vitro
    Zhou, YH
    Takekoshi, M
    Maeda, F
    Ihara, S
    Esumi, M
    ANTIVIRAL RESEARCH, 2002, 56 (01) : 51 - 59
  • [6] Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits
    Shang, DZ
    Zhai, WW
    Allain, JP
    VIROLOGY, 1999, 258 (02) : 396 - 405
  • [7] Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection
    Hjalmarsson, S
    Blomberg, J
    Grillner, L
    Pipkorn, R
    Allander, T
    JOURNAL OF MEDICAL VIROLOGY, 2001, 64 (02) : 117 - 124
  • [8] Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
    O'Shea, Daire
    Law, John
    Egli, Adrian
    Douglas, Donna
    Lund, Gary
    Forester, Sarah
    Lambert, Joshua
    Law, Mansun
    Burton, Dennis R.
    Tyrrell, D. L. J.
    Houghton, Michael
    Humar, Atul
    Kneteman, Norman
    LIVER TRANSPLANTATION, 2016, 22 (03) : 324 - 332
  • [9] THE SEROLOGY OF HEPATITIS-C VIRUS (HCV) INFECTION - ANTIBODY CROSS-REACTION IN THE HYPERVARIABLE REGION-1
    CARDOSO, MD
    SIEMONEIT, K
    NEMECEK, V
    EPPLE, S
    KOERNER, K
    KUBANEK, B
    ARCHIVES OF VIROLOGY, 1995, 140 (10) : 1705 - 1713
  • [10] Non-random Escape Pathways from a Broadly Neutralizing Human Monoclonal Antibody Map to a Highly Conserved Region on the Hepatitis C Virus E2 Glycoprotein Encompassing Amino Acids 412-423
    Keck, Zhen-yong
    Angus, Allan G. N.
    Wang, Wenyan
    Lau, Patrick
    Wang, Yong
    Gatherer, Derek
    Patel, Arvind H.
    Foung, Steven K. H.
    PLOS PATHOGENS, 2014, 10 (08)